HomeSPH • WSE
add
Sopharma AD
Previous close
zł 12.60
Year range
zł 11.40 - zł 16.60
Avg Volume
90.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (BGN) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 494.18M | 9.13% |
Operating expense | 91.86M | 21.75% |
Net income | 16.14M | -48.27% |
Net profit margin | 3.27 | -52.54% |
Earnings per share | — | — |
EBITDA | 22.00M | -53.85% |
Effective tax rate | 10.53% | — |
Balance Sheet
Total assets
Total liabilities
| (BGN) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 26.36M | 55.13% |
Total assets | 1.48B | 9.89% |
Total liabilities | 662.27M | 3.86% |
Total equity | 820.40M | — |
Shares outstanding | 165.73M | — |
Price to book | 2.60 | — |
Return on assets | 2.82% | — |
Return on capital | 3.68% | — |
Cash Flow
Net change in cash
| (BGN) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 16.14M | -48.27% |
Cash from operations | 154.16M | 951.92% |
Cash from investing | 9.45M | 219.00% |
Cash from financing | -161.56M | -790.77% |
Net change in cash | 2.05M | 177.43% |
Free cash flow | 17.66M | -45.96% |
About
Founded
1933
Website
Employees
4,896
